Prevalence of malaria |
Deaths averted | 45 | 68 | 30 | 45 | 35 | 53 | 21 | 32 | 20 | 30 |
Private expenditures averted | 38,710 | 58,070 | 33,900 | 58,070 | 36,090 | 50,850 | 31,830 | 54,130 | 31,810 | 47,720 |
Cases of CHE averted | 73 | 109 | 42 | 64 | 61 | 92 | 0 | 0 | 0 | 0 |
Malaria case fatality ratio |
Deaths averted | 46 | 67 | 30 | 45 | 35 | 52 | 21 | 31 | 20 | 30 |
Private expenditures averted | 48,310 | 48,310 | 42,370 | 42,370 | 44,600 | 44,600 | 39,450 | 39,450 | 39,135 | 39,135 |
Cases of CHE averted | 91 | 91 | 53 | 53 | 76 | 76 | 0 | 0 | 0 | 0 |
Health services utilization |
Deaths averted | 56 | 56 | 38 | 38 | 43 | 43 | 26 | 26 | 25 | 25 |
Private expenditures averted | 38,970 | 58,460 | 33,450 | 50,180 | 35,680 | 53,520 | 31,340 | 47,010 | 31,620 | 47,430 |
Cases of CHE averted | 73 | 110 | 42 | 63 | 61 | 91 | 0 | 0 | 0 | 0 |
Probability of inpatient visit |
Deaths averted | 56 | 57 | 37 | 38 | 43 | 44 | 26 | 26 | 25 | 25 |
Private expenditures averted | 47,230 | 49,390 | 41,750 | 43,000 | 43,680 | 45,500 | 39,020 | 39,890 | 38,660 | 39,610 |
Cases of CHE averted | 73 | 109 | 42 | 64 | 61 | 91 | 0 | 0 | 0 | 0 |
Efficacy |
Deaths averted | 45 | 68 | 30 | 45 | 35 | 52 | 21 | 32 | 20 | 30 |
Private expenditures averted | 38,650 | 57,970 | 33,900 | 50,850 | 35,680 | 53,520 | 31,560 | 47,350 | 31,310 | 46,960 |
Cases of CHE averted | 73 | 109 | 42 | 64 | 61 | 91 | 0 | 0 | 0 | 0 |
Cost inputs |
Government costs | 2,625,170 | 3,963,500 | 2,632,890 | 3,971,210 | 2,621,860 | 3,960,190 | 2,634,170 | 3,972,500 | 2,628,660 | 3,966,990 |
OOP outpatient costs |
Deaths averted | 56 | 56 | 38 | 38 | 43 | 43 | 26 | 26 | 25 | 25 |
Private expenditures averted | 39,850 | 56,770 | 34,600 | 50,150 | 36,680 | 52,520 | 32,040 | 46,860 | 31,820 | 46,450 |
Cases of CHE averted | 91 | 91 | 53 | 53 | 76 | 76 | 0 | 0 | 0 | 0 |